DaVita announces third quarter 2026 financial results
Consolidated revenues reached $3.578 billion with diluted earnings per share of $3.40, reflecting operating cash flow of $519 million and a $62 million impairment charge in China.
See the latest news and media coverage for DaVita. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of kidney care and dialysis services
davita.comLast updated
In short: DaVita reported higher Q3 earnings and outlined a $2.175B-$2.25B adjusted operating-income outlook for 2026.
Consolidated revenues reached $3.578 billion with diluted earnings per share of $3.40, reflecting operating cash flow of $519 million and a $62 million impairment charge in China.
Revenues were $3.554 billion, with diluted EPS of $4.02. The company saw positive patient outcomes and financial performance.
Revenues reached $3.416 billion, operating income $482 million, and diluted EPS $2.87. The company repurchased 3 million shares.
Revenues reached $3.620 billion for the quarter and $13.643 billion for the year. Adjusted diluted EPS was $3.40 quarterly and $10.78 annually. Provides 2026 guidance.
DaVita Inc (DVA) raised its fiscal 2026 adjusted EPS guidance to $14.30 to $15.20 from a prior range...
DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30,...
DaVita generated USD 3.554 billion in revenue in Q2 2026, up 5.2 percent from the year-earlier period, while operating income reached USD 579 million. Diluted...
DaVita Inc. stock (ISIN US23918K1088) is trading around USD 183 on the New York Stock Exchange after the kidney care provider ...
Track DaVita and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to DaVita and other trending companies.